After many decades of trials and errors, it is like the highest break through ever and also heartwarming, that researchers have an come up with experimental prevention of the Human Deficiency Virus (HIV), the deadly germ that degenerates to the Acquire Immune Deficiency Syndrome (AIDS). The result came as almost all hope was lost; this development is a watershed in the search for the cure of the epidemic.
The World Health Organization (WHO) and the United Nations Agency (UNAIDS) have already confirmed that the result is a day of new dawn in the school of HIV vaccine research. It is the combination of two previous unsuccessful vaccines and the vaccine helps cut the probability of being infected by the virus (HIV) up to 31 percent. This was ascertained after the world AIDS vaccine trial of more than 16000 volunteers in Thailand.
This research was sponsored by The Army of the United States in partnership with the National Institute of Allergy and Infectious Disease. The leader of the group of researchers, Col. Jerome Kim laments, that though the benefits of the result are modest and it is concrete evidence that we could have a safe and effective AIDS fighting vaccine.
The institutes Director, Dr. Anthony Fauci aptly, warned that it is not end of the road though he is impressed with the result. He further stated that this result makes him feel optimistic that possibility of improvement on the research is high. Similarly, the executive Director of the AIDS Vaccine Advocacy Coalition, Mitchell Warren, and an international group that has worked towards developing the vaccine said, the event is a mark of historic milestone
The $105 million study tested the combination of two (2) vaccines, ALVAC and AIDSVAX, in a “prime boost” approach, in which the first one primes the immune system to attack HIV, and the second one, strengthens the response. It is the third vaccine
